Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 March 2020
Date:
09/03/2020 to 12/03/2020
Update: This meeting of the PRAC will be held virtually only, with no physical presence of delegates or other visitors at the EMA building. |
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.